This Week’s CGT News: CRISPR/Cas9 improves ASOs efficacy, and more
July 2, 2025
Our latest news roundup reports on how CRISPR/Cas9 improves ASOs efficacy, Abbvie’s latest acquisition, further sickle cell disease research, and more
3 min read
False
July 2, 2025
Our latest news roundup reports on how CRISPR/Cas9 improves ASOs efficacy, Abbvie’s latest acquisition, further sickle cell disease research, and more
3 min read
July 1, 2025
Since the FDA announced plans to phase out mandatory animal testing, in silico drug discovery and development platforms are emerging. Welcome to the age of biosimulation.
6 min read
July 1, 2025
Our latest news roundup reports on thimerosal elimination, subscription termination, depression alleviation, and more
4 min read
June 26, 2025
Our latest news roundup reports on the Bayer-Tsinghua partnership expansion, GLP-1 diabetes treatments, and GSK EU acceptance of linerixibat.
3 min read
By Daniel Eisenman, James Riddle
June 18, 2025
Ophthalmology is quietly becoming gene therapy’s next big frontier. Here’s how the science, the patients, and the regulations are aligning.
8 min read
By Rob Coker
June 6, 2025
Our latest news roundup reports on Novartis’ prostate cancer trial, Sandoz’ osteoporosis biosimilars, and more.
4 min read
By Rob Coker
June 5, 2025
The IQVIA Institute’s latest report evaluates how well seven countries are prepared to support the complex infrastructure required for CAR T therapies.
5 min read
June 2, 2025
We speak with experts from Amgen and Henry Ford Health about the development and approval of Uplizna for IgG4-related disease.
9 min read
By Rob Coker
May 30, 2025
From bird flu to COVID-19 vaccines to alleged corruption in journals, we look into recent moves from US Health Secretary RFK Jr.
3 min read
By Rob Coker
May 30, 2025
Our latest news roundup reports on a new blow for Harvard, how Pfizer and Astellas’ Xtandi improves cancer survival, and more.
4 min read
False
False
False